CATNAPCognition After Obstructive Sleep Apnea (OSA) Treatment Among Native American People (CATNAP)
CATNAP MI
Apnea+6
+ Nervous System Diseases
+ Respiration Disorders
Treatment Study
Summary
Study start date: February 6, 2025
Actual date on which the first participant was enrolled.The study aims to help Native American elders who have obstructive sleep apnea (OSA) by investigating how a special program might improve their use of a breathing device called positive airway pressure (PAP) therapy. The program is called CATNAP and is designed to be culturally meaningful for American Indian participants. Researchers are interested in seeing if better adherence to this therapy can also have a positive effect on cognitive function and reduce the risk of Alzheimer's disease and other dementias. This is important because sleep disorders and cognitive decline are closely linked, and finding ways to improve both could lead to better health outcomes for this community. Participants in the study will be divided into two groups. One group will continue with the standard care, which includes using the PAP therapy device. The other group will receive the same standard care plus additional support through motivational interviewing sessions and electronic messages specifically tailored to their cultural context. Researchers will track how often participants use their PAP devices by monitoring data that is automatically sent to the cloud. The effectiveness of the intervention will be evaluated by checking participants' PAP adherence and cognitive function at the start, after three months, and after nine months. By comparing these results, the study hopes to determine if the additional support makes a significant difference in treatment adherence and cognitive health.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.140 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 40 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Missouri Breaks Industries Research Inc
Eagle Butte, United StatesOpen Missouri Breaks Industries Research Inc in Google Maps